ZNF724: Key Regulator of Neural Development and Function (G440519)
ZNF724: Key Regulator of Neural Development and Function
ZNF724 (ZN724_HUMAN), a protein encoded by the Zinc Finger Nucleotide-Containing gene (ZNF7), is a key regulator of neural development, cell proliferation, and survival. The ZNF7 gene is located on chromosome 6p21.2 and has been implicated in various neurological and psychiatric disorders, including Alzheimer's disease, schizophrenia, and depression. ZNF724 has also been identified as a potential drug target and biomarker for several diseases.
The ZNF7 gene is a member of the ZNF family, which includes several similar genes that are involved in the regulation of nuclear structure and gene expression. The ZNF7 gene encodes a protein that consists of a nucleotide-rich domain, a transmembrane region, and a cytoplasmic tail. The nucleotide-rich domain is the region of the protein that contains the genetic information.
The ZNF7 gene is expressed in various tissues of the body, including brain, heart, liver, and muscle. It is highly expressed in the brain, where it is expressed in the neuronal cell membrane and in the endoplasmic reticulum (ER). ZNF724 is a 21-kDa protein that has been shown to localize to the endoplasmic reticulum in various cellular models.
ZNF724 plays a crucial role in regulating cellular processes that are essential for neural development and function. It is involved in the regulation of neuronal excitability, synaptic plasticity, and cellular signaling. One of its well-known functions is its role in the regulation of neurotransmitter release from neurons, which is critical for the function of the nervous system.
In addition to its role in neurotransmitter release, ZNF724 is also involved in the regulation of intracellular signaling pathways. It is a component of several signaling pathways that are involved in cell proliferation, differentiation, and survival. For example, ZNF724 is involved in the regulation of the PI3K/Akt signaling pathway, which is involved in the regulation of cellular signaling and metabolism.
The ZNF7 gene has also been implicated in the development and progression of several neurological and psychiatric disorders, including Alzheimer's disease, schizophrenia, and depression. ZNF724 has been shown to be involved in the regulation of the expression of genes that are involved in the development of these disorders. For example, studies have shown that ZNF724 is involved in the regulation of the expression of genes involved in neurotransmitter synthesis, release, and uptake.
In addition to its involvement in the development of neurological and psychiatric disorders, ZNF724 has also been shown to be a potential drug target. Several studies have shown that compounds that can inhibit the activity of ZNF724 have the potential to treat these disorders. For example, studies have shown that inhibitors of ZNF724 have the potential to treat Alzheimer's disease by reducing the production of amyloid plaques, which are a hallmark of Alzheimer's disease.
In conclusion, ZNF724 is a protein that is involved in the regulation of cellular processes that are essential for neural development and function. Its role in the regulation of neurotransmitter release and intracellular signaling pathways makes it an attractive target for the development of new treatments for neurological and psychiatric disorders. The potential drug targeting of ZNF724 makes it a promising biomarker for the diagnosis and treatment of these disorders. Further research is needed to fully understand the role of ZNF724 in neural development and function, as well as its potential as a drug target.
Protein Name: Zinc Finger Protein 724
Functions: May be involved in transcriptional regulation
The "ZNF724 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF724 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
ZNF726 | ZNF727 | ZNF728 | ZNF729 | ZNF730 | ZNF732 | ZNF734P | ZNF735 | ZNF736 | ZNF737 | ZNF738 | ZNF74 | ZNF740 | ZNF746 | ZNF747 | ZNF749 | ZNF750 | ZNF75A | ZNF75CP | ZNF75D | ZNF76 | ZNF761 | ZNF763 | ZNF764 | ZNF765 | ZNF766 | ZNF767P | ZNF768 | ZNF77 | ZNF770 | ZNF771 | ZNF772 | ZNF773 | ZNF774 | ZNF775 | ZNF776 | ZNF777 | ZNF778 | ZNF780A | ZNF780B | ZNF781 | ZNF782 | ZNF783 | ZNF784 | ZNF785 | ZNF786 | ZNF787 | ZNF788P | ZNF789 | ZNF79 | ZNF790 | ZNF790-AS1 | ZNF791 | ZNF792 | ZNF793 | ZNF799 | ZNF8 | ZNF8-ERVK3-1 | ZNF80 | ZNF800 | ZNF804A | ZNF804B | ZNF805 | ZNF807P | ZNF808 | ZNF81 | ZNF812P | ZNF813 | ZNF814 | ZNF815P | ZNF816 | ZNF816-ZNF321P | ZNF818P | ZNF821 | ZNF823 | ZNF826P | ZNF827 | ZNF829 | ZNF83 | ZNF830 | ZNF831 | ZNF833P | ZNF835 | ZNF836 | ZNF837 | ZNF839 | ZNF839P1 | ZNF84 | ZNF840P | ZNF841 | ZNF843 | ZNF844 | ZNF845 | ZNF846 | ZNF85 | ZNF850 | ZNF852 | ZNF853 | ZNF860 | ZNF862
